Anavex Life Sciences Corp (AVXL)

[flsh56]

"Please explain to all of us how Anavex is supposed to PIONEER “the inclusion of advanced genomic biomarkers” in CNS precision medicine trials in 2018 under the NEW FDA guidelines released LAST WEEK without hiring Ariana & Illumina to perform pk/pd precision medicine & genomic sequencing analysis on our participants?"

What speaks volumes is that when these NEW FDA guidelines rolled out last week, all the aforementioned pioneering was already completed.

... enough said!